CAR T-cell therapy, which transforms patients’ own immune cells into cancer-fighting warriors, has been extremely effective ...

CAR-T stands for Chimeric Antigen Receptor T-cell therapy. Doctors harvest the patient’s T cells, the soldiers of the immune ...

Researchers at UCLA have created an “off-the-shelf" cell-based immunotherapy that can seek out and destroy pancreatic cancer ...

ASH will recognize Rainer Storb, MD, with the Wallace H. Coulter Award for Lifetime Achievement in Hematology, the society's highest honor. See below for summaries and links to selected Fred Hutch ...

Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...

Cell therapies, which have made waves in the treatment of blood cancer, are showing potential for solid tumors.

The CAR-T Cell Therapy Market is expanding due to its high efficacy in hematological malignancies and emerging solid tumor indications. Key opportunities include advancing therapeutic applications, ...

ImmunoAdoptive Cell Therapy (ImmunoACT), a pioneer in cell and gene therapy, announced a strategic partnership with US firm ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

The U.S. CAR T-cell therapies market size is valued at USD 2.71 billion in 2025 and is predicted to hit around USD 42.61 ...

Adult patients with an aggressive form of leukemia will be able to receive a breakthrough immunotherapy, which was invented ...

The CAR T Vision Steering Committee has set an ambitious goal: to double the proportion of eligible patients treated with CAR T by 2030. 2 Reimbursement challenges stand out as an area where ...